Sayer Ji's Substack

Sayer Ji's Substack

Share this post

Sayer Ji's Substack
Sayer Ji's Substack
Reclassifying DCIS: A Groundbreaking Shift in Breast Cancer Diagnosis After Over a Decade of Advocacy

Reclassifying DCIS: A Groundbreaking Shift in Breast Cancer Diagnosis After Over a Decade of Advocacy

For over a decade, GreenMedInfo has championed the classification of ductal carcinoma in situ (DCIS) as something other than cancer, standing firm against the tide of overdiagnosis and overtreatment.

Sayer Ji's avatar
Sayer Ji
Dec 13, 2024
∙ Paid
118

Share this post

Sayer Ji's Substack
Sayer Ji's Substack
Reclassifying DCIS: A Groundbreaking Shift in Breast Cancer Diagnosis After Over a Decade of Advocacy
24
Share

Quick Summary:

  • GreenMedInfo’s Advocacy: Since 2008, GreenMedInfo has worked to redefine DCIS based on evidence showing its non-invasive nature.

  • COMET Study Validation: Recent findings affirm that active monitoring is often safer and equally effective compared to aggressive treatments.

  • Future Implications: A shift in the DCIS classification could drasticall…

Keep reading with a 7-day free trial

Subscribe to Sayer Ji's Substack to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Sayer Ji
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share